Novavax, Inc.


Market Cap$579.7M

Compare Novavax

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novavax, Inc.Novavax, Inc.-1.10%81%0.7-0.3
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

363% upside

Undervalued by 363% based on the discounted cash flow analysis.

Share Statistics

Market cap$579.70 Million
Enterprise Value$150.70 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-5.95
Outstanding Shares118,790,222
Avg 30 Day Volume8,028,132


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.06
Price to Sales0.66
Price to Book Ratio-0.88
Enterprise Value to Revenue0.14
Enterprise Value to EBIT-0.24
Enterprise Value to Net Income-1
Total Debt to Enterprise1.47
Debt to Equity-0.33

Revenue Sources

No data

ESG Score

No data

About Novavax, Inc.

CEO: Stanley Erck